Recombinant protein folding and production;Repliement et production de protéines recombinantes

Medecine/Sciences

Volumn 21, Issue 6-7, 2005, Pages 613-617

  Betton, Jean Michel ^a   Chaffotte, Alain ^a  

^a INSTITUT PASTEUR   (France)

Author keywords

[No Author keywords available]

Indexed keywords

RECOMBINANT PROTEIN;

BIOTECHNOLOGY; GENETIC SCREENING; PROTEIN AGGREGATION; PROTEIN FOLDING; PROTEIN RENATURATION; PROTEIN SYNTHESIS; REVIEW; SOLUBILIZATION;

EID: 22144475153     PISSN: 07670974     EISSN: None     Source Type: Journal    
DOI: 10.1051/medsci/2005216-7613     Document Type: Review

References (24)

1. Pavlou AK, Reichert JM. Recombinant protein therapeutics: success rates, market trends and values to 2010. Nat Biotechnol 2004; 22: 1513-9.
2. Braun P, LaBaer J. High throughput protein production for functional proteomics. Trends Biotechnol 2003; 21: 383-8.
3. Gustafsson C, Govindarajan S, Minshull J. Codon bias and heterologous protein expression. Trends Biotechnol 2004; 22: 346-53.
4. Brekke OH, Sandlie I. Therapeutic antibodies for human diseases at the dawn of the twenty-first century. Nat Rev Drug Discov 2003; 2: 52-62.
5. Gerngross TU. Advances in the production of human therapeutic proteins in yeast and filamentous fungi. Nat Biotechnol 2004; 22: 1409-14.
6. Wurm FM. Production of recombinant protein therapeutics in cultivated mammalian cells. Nat Biotechnol 2004; 22: 1393-8.
7. Hellwig S, Drossard J, Twyman RM, Fischer R. Plant cell cultures for the production of recombinant proteins. Nat Biotechnol 2004; 22: 1415-22.
8. Ritz D, Beckwith J. Roles of thiol-redox pathways in bacteria. Annu Rev Microbiol 2001; 55: 21-48.
9. Wilkinson B, Gilbert HF. Protein disulfide isomerase. Biochem Biophys Acta 2004; 1699: 35-44.
10. Spirin AS. High-throughput cell-free systems for synthesis of functionally active proteins. Trends Biotechnol 2004; 22.
11. Betton JM. Rapid translation system (RTS): a promising alternative for recombinant protein production. Curr Protein Pept Sci 2003; 4: 73-80.
12. Broun P, Hu V, Shen B, et al. Proteome-scale purification of human proteins from bacteria. Proc Natl Acad Sci USA 2002; 99: 2654-9.
13. Kiefhaber T, Rudolph R, Kohler H-H, Buchner J. Protein aggregation in vitro and in vivo: a quantitative model of the kinetic competition between folding and aggregation. Biotechnology 1991; 9: 825-9.
14. Fink AL. Protein aggregation: folding aggregates, inclusion bodies and amyloid. Fold Design 1998; 3: R9-23.
15. Carrio MM, Villaverde A. Construction and deconstruction of bacterial inclusion bodies. J Biotechnol 2002; 96: 3-12.
16. Fischer G, Tradler T, Zarnt T. The mode of action of peptidyl prolyl cis/trans isomerases in vivo: binding versus catalysis. FEBS Lett 1998; 426: 17-20.
17. Wickner S, Maurizi MR, Gottesman S. Posttranslational quality control: folding, refolding, and degrading proteins. Science 1999; 286: 1888-93.
18. Middelberg APJ. Preparative protein refolding. Trends Biotechnol 2002; 20: 437-43.
19. Baneyx F, Mujacic M. Recombinant protein folding and misfolding in Escherichia coli. Nat Biotechnol 2004; 22: 1399-408.
20. Clark ED, Schwartz E, Rudolph R. Inhibition of aggregation side reactions during in vitro protein folding. Meth Enzymol 1999; 309: 217-36.
21. Waldo GS, Standish BM, Berendzen J, Terwilliger TC. Rapid protein-folding assay using green fluorescent protein. Nat Biotechnol 1999; 17: 691-5.
22. Cabantous S, Terwilliger TC, Waldo GS. Protein tagging and detection with engineered self-assembling fragments of green fluorescent protein. Nat Biotechnol 2005; 23: 102-7.
23. Chirino AJ, Mire-Sluis A. Characterizing biological products and assessing comparability following manufacturing changes. Nat Biotechnol 2004; 22: 1383-91.
24. Zhang Z, Gildersleeve J, Yang YY, et al. A new strategy for the synthesis of glycoproteins. Science 2004; 303: 371-3.